DHODH and cancer: Inducing ferroptosis in cancer cells is promoted as one of the innovative possibilities in oncological therapeutics; recently it was discovered that supplementation with dihydroorotate/orotate (the first is the substrate and the second is the product of dihydroorotate dehydrogenase (DHODH)) respectively mitigate or exacerbate ferroptosis and mitochondria lipid peroxidation.347